Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Lycera Corporation patents

Recent patent applications related to Lycera Corporation. Lycera Corporation is listed as an Agent/Assignee. Note: Lycera Corporation may have other listings under different names/spellings. We're not affiliated with Lycera Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Lycera Corporation-related inventors




Date Lycera Corporation patents (updated weekly) - BOOKMARK this page
07/06/17Benzenesulfonamido and related compounds for use as agonists of rory and the treatment of disease
06/29/17Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
01/12/17Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma & related therapeutic methods
11/03/16Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of rory and the treatment of disease
10/27/16Carbamate benzoxazine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
10/20/16N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/20/16Alkylpyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/20/16Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease
10/20/162-acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of rorgamma activity and the treatment of disease
10/06/16Trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
02/11/16Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
11/26/15Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
07/02/15Trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/04/15Indazole guanidine f1f0-atpase inhibitors and therapeutic uses thereof
05/28/15Heterocyclic guanidine f1f0-atpase inhibitors and therapeutic uses thereof
05/14/15Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of rory and the treatment of disease
05/07/15Bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of disease
04/30/15Saturated acyl guanidine for inhibition of f1f0-atpase
04/23/15Tetrahydronaphthyridine and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease
01/29/15Methods and compositions for detecting immune system activation
03/27/14N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease
02/20/14Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
12/05/13Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Lycera Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Lycera Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';